AnaBios is pleased to announce that Gatehouse Bio Chief Executive Officer Dr. David W. Salzman is the winner of the 2024 Translational Research Grant Award. Dr. Salzman will obtain up to $15,000 in AnaBios’ high-quality...
Read MoreIt is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout.

Dedicated to clinically relevant research models
AnaBios is pleased to announce that Gatehouse Bio Chief Executive Officer Dr. David W. Salzman is the winner of the 2024 Translational Research Grant Award. Dr. Salzman will obtain up to $15,000 in AnaBios’ high-quality...
Read MoreAnaBios is pleased to announce that Dr. Kristine Griffett, Assistant Professor of Pharmacology at Auburn University, is the winner of our third annual Translational Research Grant Award. Dr. Griffett will obtain up to $15,000 in...
Read MoreSAN DIEGO, CA – April 4, 2023 – AnaBios Corporation today announced the acquisition of Cell Systems, a human primary cell and cell culture media company located in Kirkland, Washington. The purchase of Cell Systems will...
Read MoreThe agreement will drive the discovery of more effective treatments for cardiovascular disease and development of safer drugs with the pre-clinical implementation of advanced human heart models. SAN DIEGO, CA – February 14, 2023 – AnaBios,...
Read MoreSAN DIEGO, CA – January 30, 2023 – AnaBios is pleased to announce the redesign of their website describing their human tissue platform offerings, including off-the-shelf and custom tissue samples from their industry-leading biorepository, as well...
Read More